What Happened
The World Health Organization’s 2024 global hepatitis report has identified Nigeria as one of the countries contributing disproportionately to hepatitis related mortality. While the exact figures remain under review, preliminary data suggest Nigeria accounts for a substantial share of the estimated 1.3 million annual deaths worldwide attributed to viral hepatitis. The report highlights a troubling trend: despite global progress in hepatitis prevention and treatment, Nigeria’s response has been hampered by systemic challenges, including low vaccination coverage, inadequate screening programs, and limited access to antiviral therapies.
Hepatitis B and C, the most prevalent strains in Nigeria, are transmitted through contact with infected blood, unprotected sexual activity, and mother to child transmission during childbirth. The country’s high prevalence, estimated at 8 to 12 percent for hepatitis B and 1 to 2 percent for hepatitis C, places it among the most affected nations in sub Saharan Africa. Yet, public awareness remains alarmingly low, with many Nigerians unaware of their infection until symptoms become severe.
Why Public Health Officials Are Concerned
The WHO’s findings have raised alarms among public health officials for several reasons. First, hepatitis is a leading cause of liver cirrhosis and hepatocellular carcinoma, two conditions that impose a heavy burden on Nigeria’s already strained healthcare system. Second, the disease disproportionately affects young adults, the demographic that forms the backbone of the nation’s workforce and economy. Third, the lack of routine screening means that most infections go undetected until late stages, when treatment options are limited and costly.
Compounding the crisis is the fact that hepatitis B is vaccine preventable, yet Nigeria’s national immunization program has struggled to achieve universal coverage. While the hepatitis B vaccine is included in the routine childhood immunization schedule, logistical challenges, vaccine hesitancy, and gaps in healthcare access have left millions of children unprotected. For hepatitis C, which has no vaccine, the focus must shift to screening and early treatment with direct acting antivirals, a strategy that has proven highly effective in other regions but remains out of reach for most Nigerians due to cost and availability.
Symptoms or Risk Factors
Viral hepatitis often progresses silently, with many individuals experiencing no symptoms until the liver is significantly damaged. When symptoms do appear, they may include:
- Persistent fatigue and weakness
- Jaundice, or yellowing of the skin and eyes
- Dark urine and pale stools
- Abdominal pain or swelling
- Nausea, vomiting, and loss of appetite
- Unexplained weight loss
Risk factors for hepatitis B and C in Nigeria include:
- Unprotected sexual contact with an infected partner
- Sharing needles or other drug injection equipment
- Receiving unscreened blood transfusions or medical procedures with unsterilized equipment
- Mother to child transmission during childbirth
- Traditional practices such as scarification, tattooing, or circumcision performed with non sterile instruments
- Occupational exposure among healthcare workers
Who May Be Affected
The hepatitis crisis in Nigeria cuts across all demographics, but certain groups face heightened risks. Infants born to mothers with hepatitis B are at particularly high risk of chronic infection, which can lead to liver cancer later in life if left untreated. Young adults, especially those engaging in unprotected sex or intravenous drug use, are also vulnerable. Additionally, healthcare workers, patients requiring frequent blood transfusions, and individuals in correctional facilities face elevated exposure risks due to their environments.
Rural communities, where healthcare access is limited and traditional medical practices are common, are disproportionately affected. In these areas, awareness of hepatitis transmission and prevention remains low, and diagnostic tools are often unavailable. Urban populations are not immune, however, as crowded living conditions and inadequate sanitation can facilitate the spread of hepatitis A and E, which are transmitted through contaminated food and water.
Government or WHO Response
The Nigerian government, in collaboration with the WHO and other international partners, has taken initial steps to address the hepatitis crisis. In 2020, the Federal Ministry of Health launched the National Viral Hepatitis Control Program, which aims to reduce hepatitis related morbidity and mortality through prevention, diagnosis, and treatment. Key components of the program include:
- Expanding access to hepatitis B vaccination for infants and high risk adults
- Scaling up screening and diagnostic services, particularly in primary healthcare centers
- Improving blood safety protocols to prevent transfusion related transmission
- Training healthcare workers on hepatitis prevention, diagnosis, and management
- Raising public awareness through community outreach and media campaigns
The WHO has also provided technical support to Nigeria, including guidelines for hepatitis testing and treatment, as well as assistance in strengthening surveillance systems. However, experts argue that progress has been slow, with funding constraints and competing health priorities, such as malaria, HIV/AIDS, and COVID 19, diverting attention and resources away from hepatitis.
Prevention and Safety Guidance
Preventing hepatitis requires a multi faceted approach that combines vaccination, safe practices, and public education. Here are key strategies to reduce the risk of infection:
- Vaccination: The hepatitis B vaccine is highly effective and is recommended for all infants, healthcare workers, and individuals at high risk. Nigeria’s routine immunization schedule includes the hepatitis B vaccine at birth, 6 weeks, 10 weeks, and 14 weeks of age. Adults who have not been vaccinated should consider getting the three dose series.
- Safe Injection Practices: Avoid sharing needles, syringes, or other drug injection equipment. Healthcare facilities must adhere to strict sterilization protocols for medical instruments.
- Blood Safety: Ensure that any blood transfusions or medical procedures are performed with screened and safe blood products. Patients should advocate for testing in healthcare settings.
- Safe Sex: Use condoms to reduce the risk of sexual transmission of hepatitis B and C.
- Hygiene and Sanitation: Practice good hand hygiene and ensure food and water are safe to prevent hepatitis A and E, which are spread through fecal oral routes.
- Screening and Early Detection: Individuals at high risk, including pregnant women, healthcare workers, and those with a history of blood transfusions, should undergo regular screening for hepatitis B and C. Early detection allows for timely treatment and reduces the risk of complications.
What Readers Should Know
Hepatitis is not an inevitable fate. With the right tools and knowledge, Nigeria can turn the tide against this silent epidemic. For individuals, the message is clear: get vaccinated, get tested, and adopt safe practices to protect yourself and your loved ones. For policymakers and healthcare leaders, the call to action is equally urgent: prioritize hepatitis in national health agendas, invest in screening and treatment infrastructure, and launch sustained public awareness campaigns to educate communities.
The WHO’s report serves as a wake up call, but it also offers a roadmap for change. Countries like Egypt and Rwanda have demonstrated that with political will and targeted interventions, hepatitis can be controlled and even eliminated. Nigeria has the opportunity to follow suit, but the window for action is narrowing. The time to act is now, before another life is lost to a preventable disease.
Key Takeaways
- Nigeria is among the countries with the highest hepatitis related deaths globally, according to the WHO’s 2024 report, with hepatitis B and C being the most prevalent strains.
- Hepatitis often progresses silently, with many individuals unaware of their infection until severe liver damage or cancer develops, making early screening and vaccination critical.
- Prevention strategies include vaccination (especially for hepatitis B), safe injection practices, blood safety, protected sex, and regular screening for high risk groups.
- The Nigerian government and WHO have initiated programs to combat hepatitis, but funding constraints and competing health priorities have slowed progress.
- Public awareness, healthcare access, and political commitment are essential to reversing Nigeria’s hepatitis crisis and preventing needless deaths.
Frequently Asked Questions
What is hepatitis, and how is it transmitted?
Hepatitis is an inflammation of the liver caused by viral infections, most commonly hepatitis A, B, C, D, and E. Hepatitis B and C, the most prevalent strains in Nigeria, are primarily transmitted through contact with infected blood, unprotected sexual activity, and mother to child transmission during childbirth. Hepatitis A and E are typically spread through contaminated food and water.
Why is Nigeria’s hepatitis burden so high?
Nigeria’s high hepatitis burden is attributed to several factors, including low vaccination coverage, limited public awareness, inadequate screening programs, unsafe medical practices, and high rates of mother to child transmission. Additionally, systemic challenges such as healthcare infrastructure gaps and funding constraints have hindered effective prevention and treatment efforts.
Is there a vaccine for hepatitis?
Yes, there is a highly effective vaccine for hepatitis B, which is included in Nigeria’s routine childhood immunization schedule. However, there is currently no vaccine for hepatitis C. Prevention for hepatitis C relies on safe practices, such as avoiding needle sharing and ensuring blood safety during medical procedures.
What are the symptoms of hepatitis?
Hepatitis often progresses without symptoms in its early stages. When symptoms do appear, they may include fatigue, jaundice (yellowing of the skin and eyes), dark urine, pale stools, abdominal pain, nausea, and unexplained weight loss. Chronic hepatitis can lead to severe liver damage, cirrhosis, or liver cancer.
How can I protect myself and my family from hepatitis?
To protect yourself and your family from hepatitis, follow these steps: get vaccinated for hepatitis B, practice safe sex, avoid sharing needles or other drug injection equipment, ensure blood transfusions and medical procedures use screened and safe blood products, and maintain good hygiene to prevent hepatitis A and E. Regular screening is also recommended for high risk individuals.
What should I do if I suspect I have hepatitis?
If you suspect you have hepatitis, seek medical attention immediately. A healthcare provider can perform blood tests to diagnose the infection and determine the appropriate course of action. Early detection and treatment can prevent complications and reduce the risk of transmission to others.
Medical Review: MedSense Editorial Board
DISCUSSION (0)
POST A COMMENT